Keyword

Q203

Description: An experimental antituberculosis drug, also called telacebec, that inhibits the cytochrome bc1 complex in Mycobacterium tuberculosis.
Wikidata ID: wiki/Q27261307
OpenAlex ID: keywords/q203
2013 · Kevin Pethe, Pablo Bifani, et al. · Nature Medicine · 643
2016 · Dirk A. Lamprecht, Peter M. Finin, et al. · Nature Communications · 245
2020 · Bei Shi Lee, Kiel Hards, et al. · EMBO Molecular Medicine · 108
2017 · Yi‐Hung Chen, Simon Graßl, et al. · Angewandte Chemie International Edition · 96
2018 · Nicole Scherr, Raphael Bieri, et al. · Nature Communications · 88
2016 · Sunhee Kang, Young Mi Kim, et al. · European Journal of Medicinal Chemistry · 47
2020 · Sapna Bajeli, Navin Baid, et al. · Frontiers in Cellular and Infection Microbiology · 44
2021 · Jeongjun Kim, Jinho Choi, et al. · Antimicrobial Agents and Chemotherapy · 42
2021 · Aparna Bahuguna, Srishti Rawat, et al. · Medicinal Research Reviews · 39
2020 · Milan Urban, Veronika Šlachtová, et al. · European Journal of Medicinal Chemistry · 36
2020 · Deepak V. Almeida, Paul J. Converse, et al. · Antimicrobial Agents and Chemotherapy · 34
2017 · Jichan Jang, Ryangyeo Kim, et al. · Antimicrobial Agents and Chemotherapy · 34
2019 · Paul J. Converse, Deepak V. Almeida, et al. · Antimicrobial Agents and Chemotherapy · 33
2019 · Ria Sorayah, Malathy Sony Subramanian Manimekalai, et al. · ACS Infectious Diseases · 30
2017 · Sunhee Kang, Young Mi Kim, et al. · European Journal of Medicinal Chemistry · 29
Works count: 92
Citation count: 2,666
Year
Topic
Type